Evidence map›Paper›PMID 20305717›Full record

ArticlePLoS biology2010

Spatial epigenetic control of mono- and bistable gene expression.

János Z Kelemen, Prasuna Ratna, Simone Scherrer, Attila Becskei

Open access · goldAbstract read
In one paragraph

Article in PLoS biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Tuning up Transcription Factors for Therapy.Molecules (Basel, Switzerland) · 2020
    Review
  3. Article
  4. AFrontiers in microbiology · 2018
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

János Z KelemenInstitute of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.
Prasuna Ratna
Simone Scherrer
Attila Becskei
University of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bistability in signaling networks is frequently employed to promote stochastic switch-like transitions between cellular differentiation states. Differentiation can also be triggered by antagonism of activators and repressors mediated by epigenetic processes that constitute regulatory circuits anchored to the chromosome. Their regulatory logic has remained unclear. A reaction-diffusion model reveals that the same reaction mechanism can support both graded monostable and switch-like bistable gene expression, depending on whether recruited repressor proteins generate a single silencing gradient or two interacting gradients that flank a gene. Our experiments confirm that chromosomal recruitment of activator and repressor proteins permits a plastic form of control; the stability of gene expression is determined by the spatial distribution of silencing nucleation sites along the chromosome. The unveiled regulatory principles will help to understand the mechanisms of variegated gene expression, to design synthetic genetic networks that combine transcriptional regulatory motifs with chromatin-based epigenetic effects, and to control cellular differentiation.

Indexed as

Epigenesis, GeneticGene Expression Regulation, FungalGene Regulatory NetworksGene SilencingBinding SitesNuclear ProteinsRecombinant Fusion ProteinsRegulatory Sequences, Nucleic AcidRepressor ProteinsSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsTranscriptional ActivationNuclear ProteinsRecombinant Fusion ProteinsRepressor ProteinsSaccharomyces cerevisiae ProteinsSUM1 protein, S cerevisiae

Identifiers

PMID20305717
PMCPMC2838748
OpenAlexW2038248051

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.